Nosis Bio is revolutionizing RNA therapeutic development with its proprietary Connexa platform, which enables receptor-targeted RNA medicines for chronic diseases. The company focuses on cell-specific delivery, aiming to reduce the cost and risk associated with new therapeutic development. With a team of experts in computational biology and biochemistry, Nosis Bio is positioned to unlock therapeutic access to key cell types, enhancing the efficacy and safety of RNA medicines. Their innovative approach addresses significant challenges in the field, making them a strong contender in the RNA therapeutics market.

Operations

Berkeley, CA, USA

Nosis Bio

KdT Ventures is a new age seed stage venture firm, with a focus on the intersection of technology and science.

KdT Ventures LLC

KdT Ventures

Discover available job opportunities within our portfolio

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining KdT Ventures Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the KdT Ventures network as they come up.

You can always update this information later.

Welcome to the KdT Ventures talent network

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a KdT Ventures company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Join Us